ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

OSE OSE Immunotherapeutics

8.10
-0.26 (-3.11%)
25 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
OSE Immunotherapeutics OSE Euronext Ordinary Share
  Price Change Price Change % Share Price Last Trade
-0.26 -3.11% 8.10 01:40:00
Open Price Low Price High Price Close Price Previous Close
8.32 8.02 8.50 8.10 8.36
more quote information »

Recent News

Date Time Source Heading
22/5/202415:30GLOBEOSE Immunotherapeutics and Boehringer Ingelheim expand..
14/5/202402:00GLOBEInformations relatives au nombre total de droits de vote et..
03/5/202402:00GLOBEMise à disposition du Document d’Enregistrement Universel ..
17/4/202402:00GLOBEOSE Immunotherapeutics annonce l’entrée en vigueur de la..
11/4/202402:00GLOBEOSE Immunotherapeutics reçoit un financement public de 8,4..
04/4/202403:00GLOBEInformations relatives au nombre total de droits de vote et..
02/4/202416:30GLOBEOSE Immunotherapeutics Announces Peer-Reviewed Publication..
28/3/202404:00GLOBEOSE Immunotherapeutics publie ses résultats financiers..
18/3/202417:30BWOSE Immunotherapeutics Announces Completion of Enrollment in..
02/3/202404:00BWOSE Immunotherapeutics : Informations relatives au nombre..
28/2/202417:45BWOSE Immunotherapeutics organise un Webinaire pour commenter..
28/2/202417:30BWAbbVie et OSE Immunotherapeutics annoncent un partenariat..
27/2/202404:00BWOSE Immunotherapeutics Provides Update on Clinical Results..
03/2/202404:00BWOSE Immunotherapeutics : Informations relatives au nombre..
19/1/202417:30BWOSE Immunotherapeutics fait un point d’étape sur les..
06/1/202404:00BWOSE Immunotherapeutics : Informations relatives au nombre..
11/12/202317:30BWOSE Immunotherapeutics et le Centre Hospitalier..
06/12/202304:00BWOSE Immunotherapeutics : Informations relatives au nombre..
22/11/202304:00BWOSE Immunotherapeutics annonce un accord de collaboration..
07/11/202304:00BWOSE Immunotherapeutics : Informations relatives au nombre..
24/10/202303:00BWOSE Immunotherapeutics Announces First Clinical Results for..
16/10/202316:30BWOSE Immunotherapeutics présente les premiers résultats..
06/10/202303:00BWOSE Immunotherapeutics : Informations relatives au nombre..
28/9/202302:03BWOSE Immunotherapeutics Announces H1 2023 Results and..
20/9/202315:30BWOSE Immunotherapeutics Updates on its Research Programs in..
12/9/202302:00BWOSE Immunotherapeutics Announces: Positive Phase 3 Data from..
05/9/202302:00BWOSE Immunotherapeutics : Informations relatives au nombre..
01/8/202315:30BWOSE Immunotherapeutics annonce une nouvelle aide publique..
20/7/202302:00BWOSE Immunotherapeutics annonce une publication sur OSE-230,..
12/7/202302:00BWOSE Immunotherapeutics and Nantes University Hospital..
11/7/202302:00BWOSE Immunotherapeutics : Informations relatives au nombre..
06/7/202315:30BWOSE Immunotherapeutics Announces for Lusvertikimab, its..
05/7/202302:00BWOSE Immunotherapeutics Announces New US Patent Granted for..
23/6/202302:00BWOSE Immunotherapeutics Reports on its 2023 Combined General..
21/6/202302:00BWOSE Immunotherapeutics reçoit un financement de 1,5 M€ de..
15/6/202315:30BWOSE Immunotherapeutics Presents Update on BiCKI®IL-7, CLEC-1..
13/6/202302:00BWOSE Immunotherapeutics : Informations relatives au nombre..
06/6/202315:30BWOSE Immunotherapeutics présente des abstracts cliniques sur..
02/6/202302:00BWOSE Immunotherapeutics SA : Mise à disposition des documents..
01/6/202302:00BWLe Conseil d’administration d’OSE Immunotherapeutics propose..

Your Recent History

Delayed Upgrade Clock